Re: Additional Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Exempt Distribution

in response to

Re: Additional Exempt Distribution

Nextblockbuster

posted on Dec 06, 2023 11:43AM

"Are they being fed the same garbage rumours we are or something much more credible .... "

Throwing in that kind of money I would suggest something much more "credible"

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply